Current status of cell-based therapies for respiratory virus infections: applicability to COVID-19

The severe respiratory consequences of the coronavirus disease 2019 (COVID-19) pandemic have prompted urgent need for novel therapies. Cell-based approaches, primarily using mesenchymal stem (stromal) cells (MSCs), have demonstrated safety and possible efficacy in patients with acute respiratory dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Khoury, Maroun, Cuenca, Jimena, Cruz, Fernanda F., Figueroa, Fernando E., Rocco, Patricia R.M., Weiss, Daniel J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2020
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144273/
https://www.ncbi.nlm.nih.gov/pubmed/32265310
http://dx.doi.org/10.1183/13993003.00858-2020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144273/
https://www.ncbi.nlm.nih.gov/pubmed/32265310
http://dx.doi.org/10.1183/13993003.00858-2020

Ejemplares similares